acquired
Stage
About
Apogee Therapeutics develops novel antibody therapeutics targeting immunological and inflammatory diseases, focusing on dermatological, respiratory, and gastroenterological conditions with several programs in clinical stages.
Explore Apogee Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.